Document Library

This submission was lodged in response to the 6 January 2015 call by the Therapeutic Goods Administration to provide comment on possible options for changes to the regulation of autologous cell therapies in Australia. Our submission calls for urgent action to protect patients against risks, and to bring Australian regulations into alignment with other jurisdictions and the recommendations of leading international learned scientific and research organisations.

Submission to the TGA Public Consultation on Regulation of Autologous Stem Cell Therapies